A Paragonimiasis Patient with Allergic Reaction to Praziquantel and Resistance to Triclabendazole: Successful Treatment after Desensitization to Praziquantel

Korean Journal of Parasitology

Volumn 49, Issue 1, 2011, Pages 73-77

  Kyung, Sun Young ^a   Cho, Yong Kyun ^a   Kim, Yu Jin ^a   Park, Jeong Woong ^a   Jeong, Sung Hwan ^a   Lee, Jae Ik ^a   Sung, Yon Mi ^a   Lee, Sang Pyo ^a  

^a Gachon University College of Medicine   (South Korea)

Author keywords

Desensitization; Drug allergy; Paragonimiasis; Paragonimus; Praziquantel; Triclabendazole

Indexed keywords

CIMETIDINE; DERMATOLOGICAL AGENT; HYDROCORTISONE SODIUM SUCCINATE; IMMUNOGLOBULIN E; PIPRINHYDRINATE; PLAKON; PRAZIQUANTEL; RANITIDINE; TRICLABENDAZOLE; UNCLASSIFIED DRUG;

ADULT; ALLERGIC REACTION; ARTICLE; BLOOD ANALYSIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DESENSITIZATION; DRUG DOSE INCREASE; DRUG FEVER; DRUG HYPERSENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA; EYE SWELLING; FEMALE; GENERALIZED EDEMA; HEMOPTYSIS; HOSPITAL READMISSION; HUMAN; HUMAN TISSUE; KOREA; LABORATORY TEST; LUNG BIOPSY; PARAGONIMIASIS; PARAGONIMUS WESTERMANI; PLEURA EFFUSION; PNEUMOTHORAX; PRURITUS; SINGLE DRUG DOSE; SUBCUTANEOUS EMPHYSEMA; SUBCUTANEOUS NODULE; SYMPTOMATOLOGY; THORACOTOMY; THORAX PAIN; THORAX RADIOGRAPHY; TREATMENT OUTCOME; URTICARIA;

ANIMALS; BENZIMIDAZOLES; DESENSITIZATION, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; DRUG RESISTANCE; FEMALE; HUMANS; MIDDLE AGED; PARAGONIMIASIS; PARAGONIMUS; PRAZIQUANTEL; TREATMENT OUTCOME;

PARAGONIMUS; PARAGONIMUS WESTERMANI; TREMATODA;

EID: 79953274566     PISSN: 00234001     EISSN: 17380006     Source Type: Journal    
DOI: 10.3347/kjp.2011.49.1.73     Document Type: Article

References (20)

1. Yokogawa M. Paragonimus and paragonimiasis. Adv Parasitol 1965; 3: 99-158.
2. Im JG, Whang HY, Kim WS, Han MC, Shim YS, Cho SY. Pleuropulmonary paragonimiasis: radiologic findings in 71 patients. Am J Roentgenol 1992; 159: 39-43.
3. Sadun EH, Buck AA. Paragonimiasis in South Korea-immunodiagnostic, epidemiologic, clinical, roentgenologic and therapeutic studies. Am J Trop Med Hyg 1960; 9: 562-599.
4. Roque FT, Ludwick RW, Bell JC. Pulmonary paragonimiasis; a review with case reports from Korea and the Philippines. Ann Intern Med 1953; 38: 1206-1221.
5. Kim TS, Han J, Shim SS, Jeon K, Koh WJ, Lee I, Lee KS, Kwon OJ. Pleuropulmonary paragonimiasis: CT findings in 31 patients. Am J Roentgenol 2005; 185: 616-621.
6. Shen C, Choi MH, Bae YM, Yu G, Wang S, Hong ST. A case of anaphylactic reaction to praziquantel treatment. Am J Trop Med Hyg 2007; 76: 603-605.
7. Liu T. Allergic manifestation after pyquiton treatment of schistosomiasis. Chinese J Parasitol Parasit Dis 1984; 2: 192-203 (in Chinese).
8. Huang SW. A clinical approach to a patient with praziquantel hypersensitivity. J Allergy Clin Immunol 1992; 90: 867.
9. Cho SY, Hong ST, Rho YH, Choi SY, Han YC. Application of micro-ELISA in serodiagnosis of Human paragonimiasis. Korean J Parasitol 1981; 19: 151-156.
10. Calvopina M, Guderian RH, Paredes W, Chico M, Cooper PJ. Treatment of human pulmonary paragonimiasis with triclabendazole: clinical tolerance and drug efficacy. Trans R Soc Trop Med Hyg 1998; 92: 566-569.
11. Talaie H, Emami H, Yadegarinia D, Nava-Ocampo AA, Massoud J, Azmoudeh M, Mas-Coma S. Randomized trial of a single, double and triple dose of 10 mg/kg of a human formulation of triclabendazole in patients with fascioliasis. Clin Exp Pharmacol Physiol 2004; 31: 777-782.
12. White AA, Stevenson DD, Simon RA. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2005; 95: 330-335.
13. DeFrain M, Hooker R. North American paragonimiasis: case report of a severe clinical infection. Chest 2002; 121: 1368-1372.
14. Singh TS, Mutum SS, Razaque MA. Pulmonary paragonimiasis: clinical features, diagnosis and treatment of 39 cases in Manipur. Trans R Soc Trop Med Hyg 1986; 80: 967-971.
15. Mukae O, Taniguchi H, Ashitani J, Matsukura S, Uchiyama F, Nawa Y. Case report: paragonimiasis westermani with seroconversion from immunoglobulin IgM to IgG antibody with the clinical course. Am J Trop Med Hyg 2001; 65: 837-839.
16. Jeon K, Koh WJ, Kim H, Kwon OJ, Kim TS, Lee KS, Han J. Clinical features of recently diagnosed pulmonary paragonimiasis in Korea. Chest 2005; 128: 1423-1430.
17. Shorter D, Makone I, Elliott EJ. Fever and urticaria in an African refugee. J Paediatr Child Health 2006; 42: 731-733.
18. Brindley PJ, Sher A. Immunologic involvement in the efficacy of praziquantel. Exp Parasitol 1990; 71: 245-248.
19. Matsumoto J. Adverse effects of praziquantel treatment of Schistosoma japonicum infection: involvement of host anaphylactic reactions induced by parasite antigen release. Int J Parasitol 2002; 32: 461-471.
20. Castells M. Desensitization for drug allergy. Curr Opin Allergy Clin Immunol 2006; 6: 476-481.